T. Conroy
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in ⓘ
-
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Treatments and Mutations 3
- Oncology 9
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Surgical Treatments 2
- Co-authors
- Marc Buyse (1 shared paper)Harry Bleiberg (1 shared paper)H. E. Reis (1 shared paper)M. Fickers (1 shared paper)J. Wils (1 shared paper)Serge Leyvraz (1 shared paper)H. O. Klein (1 shared paper)D. J. Th. Wagener (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)British Journal of Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)British journal of surgery (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- FranceBelgiumNetherlands
In The Last Decade
T. Conroy
22 papers receiving 890 citations
Peers
Comparison fields: 5 of 53
- Genetics 189
- Gastroenterology 92
- Oncology 457
- Neurology 221
- Pulmonary and Respiratory Medicine 456
Countries citing papers authored by T. Conroy
This map shows the geographic impact of T. Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Conroy more than expected).
Fields of papers citing papers by T. Conroy
This network shows the impact of papers produced by T. Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Conroy. The network helps show where T. Conroy may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Conroy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 312 | |
| 2 | 1998 | 244 | |
| 3 | 1998 | 172 | |
| 4 | [Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment]. | 2006 | 39 |
| 5 | 2000 | 27 | |
| 6 | 1992 | 25 | |
| 7 | [Natural history and development of bone metastasis. Apropos of 429 cases]. | 1988 | 20 |
| 8 | [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]. | 2000 | 19 |
| 9 | 2005 | 15 | |
| 10 | 2008 | 14 | |
| 11 | 1997 | 5 | |
| 12 | [Long term continuous combination of cisplatin and 5 fluorouracil in advanced breast neoplasms. A retrospective study of 77 patients]. | 1993 | 5 |
| 13 | [Pseudolinitis plastica of breast origin]. | 1987 | 4 |
| 14 | 2007 | 4 | |
| 15 | 2004 | 4 | |
| 16 | 2001 | 3 | |
| 17 | [Cancer patient's satisfaction assessment using the EORTC QLQ-SAT32: comparison between self-assessment and interview response]. | 2005 | 2 |
| 18 | Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancer. | 1995 | 1 |
| 19 | [Chemotherapy of malignant ovarian Brenner tumors. Review of the literature apropos of 2 histological complete remissions after polychemotherapy]. | 1992 | 1 |
| 20 | 2005 | 1 |
About T. Conroy
T. Conroy is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, General Health Professions and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 919 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (5 papers), Cancer Treatment and Pharmacology (3 papers), Colorectal and Anal Carcinomas (3 papers), Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Treatments and Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Colorectal Cancer Surgical Treatments (2 papers). The work is most often cited by research in Genetics (189 citations), Gastroenterology (92 citations), Oncology (457 citations), Neurology (221 citations) and Pulmonary and Respiratory Medicine (456 citations). T. Conroy has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Marc Buyse, Harry Bleiberg, H. E. Reis, M. Fickers, J. Wils, Serge Leyvraz, H. O. Klein, D. J. Th. Wagener, F.W. Korsten and Élisabeth Luporsi. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, British journal of surgery and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.